Technology Overview
At BioMarker Pharmaceuticals, we provide interventions that will extend a healthy human lifespan by slowing the process of aging, and delaying the onset of age-related diseases.
We are using genomic and proteomic aging-intervention technologies to evaluate dietary supplements for age-related health maintenance, and to design risk assessment and diagnostic tools needed to provide people with personalized health-maintenance interventions. Ultimately, as our aging-intervention technology matures, our screening systems will allow us to develop pharmaceutical products targeted to a variety of age-related diseases.

Focus Areas
- Nutraceutical Development
- Diagnostics & Risk Assessment Development
- Therapeutic Development